Literature DB >> 11756766

Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index.

Gregory Y Lauwers1, Benoit Terris, Ulysses J Balis, Kenneth P Batts, Jean-Marc Regimbeau, Yuchiao Chang, Fiona Graeme-Cook, Hirohiko Yamabe, Iwao Ikai, Karen R Cleary, Shiro Fujita, Jean-Francois Flejou, Lawrence R Zukerberg, David M Nagorney, Jacques Belghiti, Yoshio Yamaoka, Jean-Nicolas Vauthey.   

Abstract

Despite growing information on the clinical behavior of hepatocellular carcinoma, the histologic features associated with survival are not well characterized. Clinical and pathologic data on 425 patients who underwent complete resection for hepatocellular carcinoma were reviewed. Six microscopic features, namely, microvascular invasion, nuclear pleomorphism, mitosis, tumor architecture, growth interface, and tumor necrosis, were examined. Independent predictors of survival were identified and combined into a simple prognostic index. By univariate analysis, microvascular invasion, seen in 51.3% of patients (p <0.001), nuclear grade 3, present in 42% of the cases (p <0.001), and mitosis (p <0.008) were significant predictors of poor survival. Hepatocellular carcinoma with a compact growth pattern had a better prognosis as compared with macrotrabecular (p = 0.014) and acinar (p = 0.051) patterns. By multiple regression analysis, only microvascular invasion (p <0.001) and nuclear grade 3 (p = 0.008) were independent predictors of poor survival. The predictive values of microvascular invasion and nuclear grade allowed the construction of a hepatocellular prognostic index (HPI) whereby HPI = (microvascular invasion status x 0.459) + (nuclear grade x 0.287), with microvascular invasion either absent (0) or present (1) and nuclear grade scored as 1, 2, or 3. Using a cut-off of 0.746 (corresponding to at least nuclear grade 2 with microvascular invasion), two groups could be segregated: fair prognosis (HPI < or = 0.746), with a 50% survival of 5.06 years, and poor prognosis (HPI >0.746) with a 50% survival of 2.71 years (p <0.001). HPI was more discriminating than Edmondson grade, with Edmondson II hepatocellular carcinomas dispersed in both fair and poor prognosis groups. Microvascular invasion and nuclear grade 3 emerge as strong prognostic indicators, and their combination provides adequate prognostic stratification. Practically, hepatocellular carcinoma can be stratified in two groups with regard to prognosis: 1) fair prognosis group (nuclear grade 1 with or without microvascular invasion and nuclear grade 2 without microvascular invasion), and 2) poor prognosis (nuclear grade 2 with microvascular invasion and nuclear grade 3 with or without microvascular invasion). The combination of these histologic parameters provides adequate prognostic stratification.

Entities:  

Mesh:

Year:  2002        PMID: 11756766     DOI: 10.1097/00000478-200201000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  44 in total

1.  Radiological assessment of hepatic vein invasion by hepatocellular carcinoma using combined computed tomography hepatic arteriography and computed tomography arterial portography.

Authors:  Akihiro Nishie; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa; Yasuhiro Ushijima; Daisuke Kakihara; Daisuke Okamoto; Nobuhiro Fujita; Akinobu Taketomi; Kengo Yoshimitsu; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2010-07-27       Impact factor: 2.374

2.  Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?

Authors:  Honsoul Kim; Mi-Suk Park; Jin Young Choi; Young Nyun Park; Myeong-Jin Kim; Kyung Sik Kim; Jin Sub Choi; Kwang-Hyub Han; EunJu Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

3.  Hepatocellular carcinoma: Liver biopsy in the balance.

Authors:  David E Kleiner
Journal:  Hepatology       Date:  2018-07       Impact factor: 17.425

4.  Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver.

Authors:  A Quaglia; M A Jutand; A Dhillon; A Godfrey; R Togni; P Bioulac-Sage; C Balabaud; M Winnock; A P Dhillon
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 5.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

6.  The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma.

Authors:  Ludwig Wilkens; Rolf Jaggi; Caroline Hammer; Daniel Inderbitzin; Olivier Giger; Nils von Neuhoff
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

7.  Contrast-enhanced 3D ultrasonography in minute hepatocellular carcinoma.

Authors:  Masao Ohto; Ryu Ito; Nei Soma; Hiroyuki Fukuda; Yasushi Shinohara; Akio Sakamoto; Fukuo Kondo
Journal:  J Med Ultrason (2001)       Date:  2010-09-16       Impact factor: 1.314

8.  Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study.

Authors:  Yusuke Ogihara; Yoshio Kitazume; Yoshihiro Iwasa; Shinichi Taura; Yoshiro Himeno; Tomo Kimura; Seishi Sawano; Shigehiko Terada; Minoru Tanabe; Yukihisa Saida; Ukihide Tateishi
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

9.  Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma.

Authors:  Wei-Hua Qiu; Bing-Sen Zhou; Peiguo-G Chu; Wen-Gang Chen; Christopher Chung; Jennifer Shih; Paul Hwu; Christopher Yeh; Richard Lopez; Yun Yen
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

10.  Preoperative predictors of survival after resection of small hepatocellular carcinomas.

Authors:  Jeffrey D Wayne; Gregory Y Lauwers; Iwao Ikai; Dorota A Doherty; Jacques Belghiti; Yoshio Yamaoka; Jean-Marc Regimbeau; David M Nagorney; Kim-Anh Do; Lee M Ellis; Steven A Curley; Raphael E Pollock; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.